| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 18, 2024 | Sell(S) | 2K | $42.24 | $75K | 84K |
| Jun 18, 2024 | Option exercise(M) | 2K | $4.26 | $10K | 87K |
| Jun 18, 2024 | Sell(S) | 12K | $42.24 | $493K | 84K |
| Jun 18, 2024 | Sell(S) | 2K | $42.24 | $98K | 84K |
| Jun 18, 2024 | Option exercise(M) | 12K | $30.00 | $350K | 96K |
| Jun 18, 2024 | Sell(S) | 7K | $42.24 | $303K | 77K |
| Jun 18, 2024 | Option exercise(M) | 2K | $14.10 | $25K | 86K |
| Jun 17, 2024 | Option exercise(M) | 2K | $4.26 | $8K | 86K |
| Jun 17, 2024 | Sell(S) | 9K | $46.02 | $430K | 84K |
| Jun 17, 2024 | Sell(S) | 2K | $46.02 | $81K | 84K |
| Jun 17, 2024 | Option exercise(M) | 9K | $30.00 | $280K | 94K |
| Jun 14, 2024 | Option exercise(M) | 17K | $14.10 | $237K | 101K |
| Jun 14, 2024 | Sell(S) | 17K | $50.17 | $844K | 84K |
| Jun 14, 2024 | Option exercise(M) | 12K | $4.26 | $53K | 97K |
| Jun 14, 2024 | Sell(S) | 12K | $50.17 | $626K | 84K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 18, 2024 | Option exercise(M) | 2K | — | $0 | 31K |
| Jun 18, 2024 | Option exercise(M) | 2K | — | $0 | 50K |
| Jun 18, 2024 | Option exercise(M) | 12K | — | $0 | 0 |
| Jun 17, 2024 | Option exercise(M) | 9K | — | $0 | 12K |
| Jun 17, 2024 | Option exercise(M) | 2K | — | $0 | 52K |
| Jun 14, 2024 | Option exercise(M) | 17K | — | $0 | 33K |
| Jun 14, 2024 | Option exercise(M) | 12K | — | $0 | 54K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-075071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Corbus Pharmaceuticals Holdings, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0000950170-24-075071"
Use Arkolith to summarize insider buying and selling at Corbus Pharmaceuticals Holdings, Inc. over the last 90 days and cite the filings.